Skip to main content
. 2022 Sep 20;37(1):1752–1764. doi: 10.1080/14756366.2022.2087645

Table 5.

Results of the SwissADME prediction.

  GI absorption BBB permeant Pgp substrate CYP1A2 inhibitor CYP2C19 inhibitor CYP2C9 inhibitor CYP2D6 inhibitor CYP3A4 inhibitor Lipinski #violations Bioavailability Score PAINS #alerts
5a Low No No No Yes Yes Yes Yes 2 0.17 0
5b Low No No No Yes Yes No Yes 2 0.17 0
5c Low No No No Yes Yes Yes Yes 2 0.17 0
5d Low No Yes No Yes Yes Yes Yes 2 0.17 0
5e Low No No No Yes Yes Yes Yes 2 0.17 0
5f Low No Yes No Yes Yes Yes Yes 2 0.17 0
6a High No No Yes Yes Yes Yes Yes 0 0.55 0
6b High No No Yes Yes Yes Yes Yes 0 0.55 0
6c High No No Yes Yes Yes Yes Yes 0 0.55 0
6d Low No No Yes Yes Yes Yes Yes 0 0.55 0
6e High No No Yes Yes Yes Yes Yes 0 0.55 0
6f Low No No Yes Yes Yes Yes Yes 0 0.55 0
Diflapolin Low No No Yes Yes Yes Yes Yes 1 0.55 0

(Continued)